The global Diabetic Neurological Disorder Therapeutic Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Diabetic Neurological Disorder Therapeutic Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Diabetic Neurological Disorder Therapeutic Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Diabetic Neurological Disorder Therapeutic Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetic Neurological Disorder Therapeutic Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetic Neurological Disorder Therapeutic Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Diabetic Neurological Disorder Therapeutic Drug revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Diabetic Neurological Disorder Therapeutic Drug Market Report

Report Metric	Details
Report Name	Diabetic Neurological Disorder Therapeutic Drug Market
CAGR	5%
Segment by Type	Capsule Pills Other
Segment by Application	Symmetrical Neuropathy Focal and Multifocal Neuropathy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Johnson & Johnson, Takeda, Mitsubishi Chemical, Avanir Pharmaceuticals, Dong-A Pharmaceutical Co., Ltd., Immune Pharmaceuticals, MediciNova, Sangamo BioSciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Diabetic Neurological Disorder Therapeutic Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Neurological Disorder Therapeutic Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Neurological Disorder Therapeutic Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Diabetic Neurological Disorder Therapeutic Drug Market report?

Ans: The main players in the Diabetic Neurological Disorder Therapeutic Drug Market are AstraZeneca, Johnson & Johnson, Takeda, Mitsubishi Chemical, Avanir Pharmaceuticals, Dong-A Pharmaceutical Co., Ltd., Immune Pharmaceuticals, MediciNova, Sangamo BioSciences

What are the Application segmentation covered in the Diabetic Neurological Disorder Therapeutic Drug Market report?

Ans: The Applications covered in the Diabetic Neurological Disorder Therapeutic Drug Market report are Symmetrical Neuropathy, Focal and Multifocal Neuropathy

What are the Type segmentation covered in the Diabetic Neurological Disorder Therapeutic Drug Market report?

Ans: The Types covered in the Diabetic Neurological Disorder Therapeutic Drug Market report are Capsule, Pills, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Capsule

1.2.3 Pills

1.2.4 Other

1.3 Market by Application

1.3.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Symmetrical Neuropathy

1.3.3 Focal and Multifocal Neuropathy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Perspective (2019-2030)

2.2 Global Diabetic Neurological Disorder Therapeutic Drug Growth Trends by Region

2.2.1 Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Region (2019-2024)

2.2.3 Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2025-2030)

2.3 Diabetic Neurological Disorder Therapeutic Drug Market Dynamics

2.3.1 Diabetic Neurological Disorder Therapeutic Drug Industry Trends

2.3.2 Diabetic Neurological Disorder Therapeutic Drug Market Drivers

2.3.3 Diabetic Neurological Disorder Therapeutic Drug Market Challenges

2.3.4 Diabetic Neurological Disorder Therapeutic Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Diabetic Neurological Disorder Therapeutic Drug by Players

3.1.1 Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2019-2024)

3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2019-2024)

3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Diabetic Neurological Disorder Therapeutic Drug, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio

3.4.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2023

3.5 Global Key Players of Diabetic Neurological Disorder Therapeutic Drug Head office and Area Served

3.6 Global Key Players of Diabetic Neurological Disorder Therapeutic Drug, Product and Application

3.7 Global Key Players of Diabetic Neurological Disorder Therapeutic Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Type

4.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Type (2019-2024)

4.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2025-2030)

5 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Application

5.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Application (2019-2024)

5.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

6.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type

6.2.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)

6.2.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030)

6.2.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application

6.3.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)

6.3.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030)

6.3.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

6.4 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country

6.4.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)

6.4.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type

7.2.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)

7.2.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030)

7.2.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application

7.3.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)

7.3.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030)

7.3.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

7.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country

7.4.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)

7.4.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

8.2 China Diabetic Neurological Disorder Therapeutic Drug Market Size by Type

8.2.1 China Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)

8.2.2 China Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030)

8.2.3 China Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

8.3 China Diabetic Neurological Disorder Therapeutic Drug Market Size by Application

8.3.1 China Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)

8.3.2 China Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030)

8.3.3 China Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

9.2 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Type

9.2.1 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)

9.2.2 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030)

9.2.3 Asia Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

9.3 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Application

9.3.1 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)

9.3.2 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030)

9.3.3 Asia Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

9.4 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Region

9.4.1 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024)

9.4.3 Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type

10.2.1 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application

10.3.1 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country

10.4.1 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Introduction

11.1.4 AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.1.5 AstraZeneca Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Introduction

11.2.4 Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.2.5 Johnson & Johnson Recent Developments

11.3 Takeda

11.3.1 Takeda Company Details

11.3.2 Takeda Business Overview

11.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Introduction

11.3.4 Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.3.5 Takeda Recent Developments

11.4 Mitsubishi Chemical

11.4.1 Mitsubishi Chemical Company Details

11.4.2 Mitsubishi Chemical Business Overview

11.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Introduction

11.4.4 Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.4.5 Mitsubishi Chemical Recent Developments

11.5 Avanir Pharmaceuticals

11.5.1 Avanir Pharmaceuticals Company Details

11.5.2 Avanir Pharmaceuticals Business Overview

11.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction

11.5.4 Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.5.5 Avanir Pharmaceuticals Recent Developments

11.6 Dong-A Pharmaceutical Co., Ltd.

11.6.1 Dong-A Pharmaceutical Co., Ltd. Company Details

11.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview

11.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Introduction

11.6.4 Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Developments

11.7 Immune Pharmaceuticals

11.7.1 Immune Pharmaceuticals Company Details

11.7.2 Immune Pharmaceuticals Business Overview

11.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction

11.7.4 Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.7.5 Immune Pharmaceuticals Recent Developments

11.8 MediciNova

11.8.1 MediciNova Company Details

11.8.2 MediciNova Business Overview

11.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Introduction

11.8.4 MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.8.5 MediciNova Recent Developments

11.9 Sangamo BioSciences

11.9.1 Sangamo BioSciences Company Details

11.9.2 Sangamo BioSciences Business Overview

11.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Introduction

11.9.4 Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.9.5 Sangamo BioSciences Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Avanir Pharmaceuticals

Dong-A Pharmaceutical Co. Ltd.

Immune Pharmaceuticals

Medicinova, Inc.

Sangamo BioSciences

List of Tables

Table 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Capsule

Table 3. Key Players of Pills

Table 4. Key Players of Other

Table 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2019-2024)

Table 9. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2025-2030)

Table 11. Diabetic Neurological Disorder Therapeutic Drug Market Trends

Table 12. Diabetic Neurological Disorder Therapeutic Drug Market Drivers

Table 13. Diabetic Neurological Disorder Therapeutic Drug Market Challenges

Table 14. Diabetic Neurological Disorder Therapeutic Drug Market Restraints

Table 15. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Players (2019-2024)

Table 17. Global Top Diabetic Neurological Disorder Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2023)

Table 18. Global Diabetic Neurological Disorder Therapeutic Drug Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Diabetic Neurological Disorder Therapeutic Drug, Headquarters and Area Served

Table 21. Global Key Players of Diabetic Neurological Disorder Therapeutic Drug, Product and Application

Table 22. Global Key Players of Diabetic Neurological Disorder Therapeutic Drug, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2019-2024)

Table 26. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2025-2030)

Table 28. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Application (2019-2024)

Table 30. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Application (2025-2030)

Table 32. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Diabetic Neurological Disorder Therapeutic Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Diabetic Neurological Disorder Therapeutic Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Diabetic Neurological Disorder Therapeutic Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)

Table 64. AstraZeneca Company Details

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product

Table 67. AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 68. AstraZeneca Recent Developments

Table 69. Johnson & Johnson Company Details

Table 70. Johnson & Johnson Business Overview

Table 71. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product

Table 72. Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 73. Johnson & Johnson Recent Developments

Table 74. Takeda Company Details

Table 75. Takeda Business Overview

Table 76. Takeda Diabetic Neurological Disorder Therapeutic Drug Product

Table 77. Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 78. Takeda Recent Developments

Table 79. Mitsubishi Chemical Company Details

Table 80. Mitsubishi Chemical Business Overview

Table 81. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product

Table 82. Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 83. Mitsubishi Chemical Recent Developments

Table 84. Avanir Pharmaceuticals Company Details

Table 85. Avanir Pharmaceuticals Business Overview

Table 86. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product

Table 87. Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 88. Avanir Pharmaceuticals Recent Developments

Table 89. Dong-A Pharmaceutical Co., Ltd. Company Details

Table 90. Dong-A Pharmaceutical Co., Ltd. Business Overview

Table 91. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product

Table 92. Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 93. Dong-A Pharmaceutical Co., Ltd. Recent Developments

Table 94. Immune Pharmaceuticals Company Details

Table 95. Immune Pharmaceuticals Business Overview

Table 96. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product

Table 97. Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 98. Immune Pharmaceuticals Recent Developments

Table 99. MediciNova Company Details

Table 100. MediciNova Business Overview

Table 101. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product

Table 102. MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 103. MediciNova Recent Developments

Table 104. Sangamo BioSciences Company Details

Table 105. Sangamo BioSciences Business Overview

Table 106. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product

Table 107. Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

Table 108. Sangamo BioSciences Recent Developments

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type: 2023 VS 2030

Figure 3. Capsule Features

Figure 4. Pills Features

Figure 5. Other Features

Figure 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2023 VS 2030

Figure 8. Symmetrical Neuropathy Case Studies

Figure 9. Focal and Multifocal Neuropathy Case Studies

Figure 10. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered

Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Diabetic Neurological Disorder Therapeutic Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region: 2023 VS 2030

Figure 14. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players in 2023

Figure 15. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2023

Figure 17. North America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

Figure 19. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

Figure 20. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)

Figure 21. United States Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

Figure 25. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

Figure 26. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)

Figure 27. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

Figure 35. China Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

Figure 36. Asia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

Figure 38. Asia Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

Figure 39. Asia Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2019-2030)

Figure 40. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)

Figure 50. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. AstraZeneca Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 57. Johnson & Johnson Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 58. Takeda Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 59. Mitsubishi Chemical Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 60. Avanir Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 61. Dong-A Pharmaceutical Co., Ltd. Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 62. Immune Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 63. MediciNova Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 64. Sangamo BioSciences Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Diabetes Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Blood Pressure Disorders Drug Market Insights Forecast to 2030

Global Diabetic Tests Market Insights Forecast to 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Leishmaniasis Treatment Market Insights Forecast to 2030

Global Mental Health Technology Market Insights Forecast to 2030

Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030

Global Osteoporosis Treatment Market Insights Forecast to 2030

Global Mental Health Care Software and Services Market Insights Forecast to 2030

Global Chronic Obstructive Pulmonary Disease COPD Treatment Market Insights Forecast to 2030

Global Diabetes Software Market Insights Forecast to 2030

Global Diabetes Care Drugs Market Insights Forecast to 2030

Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030

Global Drug Discovery Assays Market Insights Forecast to 2030

Global Systemic Lupus Erythematosus Treatment Market Insights Forecast to 2030

Global Atherosclerosis Drugs Market Insights Forecast to 2030

Global Systemic Inflammatory Response Syndrome Treatment Market Insights Forecast to 2030

Global Staphylococcal Infection Treatment Market Insights Forecast to 2030

Global Diabetic Gastroparesis Drugs Market Insights Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-26G17123

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Global Hydrocephalus Shunts Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-9139

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Global Neurological Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26F14436

Fri May 30 00:00:00 UTC 2025

Add to Cart

Global Medications for Autism Spectrum Disorder Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34S14770

Fri May 30 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Diabetic Neurological Disorder Therapeutic Drug Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-10E13598

Global Diabetic Neurological Disorder Therapeutic Drug Market Insights, Forecast to 2030

FEATURED COMPANIES

Diabetic Neurological Disorder Therapeutic Drug Market Size

Diabetic Neurological Disorder Therapeutic Drug Market

Scope of Diabetic Neurological Disorder Therapeutic Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Diabetic Neurological Disorder Therapeutic Drug Market report?

What are the Application segmentation covered in the Diabetic Neurological Disorder Therapeutic Drug Market report?

What are the Type segmentation covered in the Diabetic Neurological Disorder Therapeutic Drug Market report?

FEATURED COMPANIES

RELATED REPORTS